MedPath

Clonazepam

CLONAZEPAM TABLETS, USP   CIV

Approved
Approval ID

68bf5bfa-8357-44ed-82ff-ad80a11789c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 25, 2018

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clonazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-2823
Application NumberANDA074869
Product Classification
M
Marketing Category
C73584
G
Generic Name
Clonazepam
Product Specifications
Route of AdministrationORAL
Effective DateNovember 21, 2017
FDA Product Classification

INGREDIENTS (6)

CLONAZEPAMActive
Quantity: 0.5 mg in 1 1
Code: 5PE9FDE8GB
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C RED NO. 30Inactive
Code: 2S42T2808B
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clonazepam - FDA Drug Approval Details